|
Mar 13
|
Director Richard Pops Sells Shares of Neurocrine Biosciences Inc (NBIX)
|
|
Mar 11
|
Neurocrine Biosciences to Participate at Virtual Investor Conferences in March
|
|
Mar 11
|
The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher
|
|
Jan 31
|
AMLX vs. NBIX: Which Stock Should Value Investors Buy Now?
|
|
Jan 31
|
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
|
|
Jan 25
|
Neurocrine Biosciences Inc's Chief Legal Officer Sells Shares
|
|
Jan 12
|
Neurocrine Biosciences Inc CEO Kevin Gorman Sells 167,858 Shares
|
|
Jan 10
|
How Neurocrine (NBIX) Stock Stands Out in a Strong Industry
|
|
Jan 5
|
Director William Rastetter Sells Shares of Neurocrine Biosciences Inc (NBIX)
|
|
Jan 2
|
Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 26
|
13 High Growth Healthcare Stocks to Buy
|
|
Dec 20
|
Here’s Why Neurocrine Biosciences (NBIX) Rose in Q3
|
|
Dec 10
|
Insider Sell Alert: Chief Legal Officer Darin Lippoldt Sells Shares of Neurocrine Biosciences Inc
|
|
Dec 9
|
Insider Sell: Chief Medical Officer Eiry Roberts Sells Shares of Neurocrine Biosciences Inc
|
|
Dec 5
|
Neurocrine Biosciences Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Crinecerfont in Congenital Adrenal Hyperplasia
|
|
Dec 2
|
Insider Sell Alert: Chief Scientific Officer Jude Onyia Sells Shares of Neurocrine Biosciences Inc
|
|
Dec 1
|
Neurocrine Biosciences to Host Analyst Day on December 5, 2023
|
|
Nov 30
|
Neurocrine Biosciences Inc's Chief Legal Officer Darin Lippoldt Sells Shares: An Insider Analysis
|
|
Nov 8
|
Neurocrine Biosciences Launches Interactive Digital Tool for use by Healthcare Providers to Help Expand Education on Identifying and Diagnosing Tardive Dyskinesia
|
|
Nov 8
|
Neurocrine Biosciences to Present at the Jefferies London Healthcare Conference
|